WIPI2 Protein

📖 Wiki Page

protein1333 wordssynced 2026-04-02

WIPI2 Protein

Overview

WIPI2 (WD repeat domain, phosphoinositide-interacting protein 2) is a highly conserved member of the PROPPIN (beta-Propeller Proteins that bind Phosphoinositides) family of proteins that function as essential effectors of phosphatidylinositol 3-phosphate (PI3P) in the autophagic process. WIPI2 plays a critical role in autophagosome formation by acting as a PI3P effector that bridges early autophagosome formation events with the ATG (autophagy-related) conjugation system. Through direct interactions with ATG16L1 and recruitment of the ATG12-ATG5-ATG16L1 complex to the isolation membrane (omegasome), WIPI2 enables LC3 lipidation—the covalent attachment of phosphatidylethanolamine to LC3 (microtubule-associated protein 1A/1B-light chain 3)—which is essential for autophagosome closure and function[@dooley2014].

In the central nervous system, autophagy is particularly important for neuronal homeostasis due to the post-mitotic nature of neurons, which cannot dilute damaged proteins and organelles through cell division. WIPI2-mediated autophagy is critical for clearing misfolded proteins (amyloid-beta, tau, alpha-synuclein), maintaining synaptic function, and ensuring neuronal survival. Dysregulated WIPI2 function has been strongly implicated in Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders[@nixon2013].

This page provides comprehensive information about WIPI2 protein structure, its role in autophagy and neuronal function, and its contributions to neurodegenerative disease pathogenesis and therapy.

...

WIPI2 Protein

Overview

This page provides comprehensive information about WIPI2 protein structure, its role in autophagy and neuronal function, and its contributions to neurodegenerative disease pathogenesis and therapy.

Molecular Characteristics

Gene and Protein Structure

The WIPI2 gene (WIPI2, also known as WIPI-2) is located on chromosome 7q36.3 and encodes a 445-amino acid protein with a molecular mass of approximately 46 kDa. WIPI2 belongs to the PROPPIN family, characterized by seven WD40 repeat beta-propeller architecture and specific phosphoinositide-binding motifs.

| Region | Residues | Function |
|--------|---------|----------|
| N-terminal region | 1-50 | Membrane association, PI3P binding |
| WD40 repeats (1-7) | 51-420 | Beta-propeller scaffold for protein interactions |
| FRRG motif | 331-334 | Critical PI3P-binding site |
| C-terminal region | 421-445 | Protein interactions, dimerization |

WIPI2 exists in two main isoforms—WIPI2a (445 aa) and WIPI2b (446 aa)—generated through alternative splicing. These isoforms show distinct subcellular localizations, with WIPI2b showing predominant association with the Golgi apparatus and WIPI2a being more evenly distributed in the cytoplasm.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">WIPI2 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>WIPI2 (WD40 repeat protein interacting with PI3P)</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[WIPI2](/genes/wipi2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y5P8](https://www.uniprot.org/uniprot/Q9Y5P8)</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>4CRR, 4D5H, 6C94</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>46 kDa</td></tr>
<tr><td><strong>Protein Length</strong></td><td>445 amino acids</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytoplasmic membranes (PI3P-enriched), isolation membrane, autophagosome</td></tr>
<tr><td><strong>Protein Family</strong></td><td>PROPPIN family (beta-propeller, PI3P binding)</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>7q36.3</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">296 edges</a></td>
</tr>
</table>
</div>

Structural Features

WIPI2 adopts the characteristic seven-bladed beta-propeller structure of the PROPPIN family:

Beta-propeller scaffold: Seven WD40 repeats form a torus-shaped structure with a central channel

FRRG motif: Located in the top face of the propeller; essential for PI3P binding

Phosphatidylinositol 3-phosphate binding: WIPI2 selectively binds PI3P through the FRRG motif

Dimerization interface: WIPI2 can form dimers through C-terminal interactions

Protein interaction surfaces: Multiple sites for ATG proteins

Family Members

The mammalian PROPPIN family consists of four members:

| Protein | Gene | PI3P Binding | Autophagy Function |
|---------|------|-------------|---------------|
| WIPI1 | WIPI1 | Yes | PI3P effector |
| WIPI2 | WIPI2 | Yes | Essential for LC3 lipidation |
| WIPI3 | WDR45 | Yes | Alternative autophagy |
| WIPI4 | WDR45L | No | Non-essential |

Autophagy Functions

Role in Autophagosome Formation

WIPI2 is essential for the late stages of autophagosome formation, specifically the recruitment of the LC3 conjugation system:

Mermaid diagram (expand to render)

WIPI2 in the Autophagy Pathway

The role of WIPI2 in autophagy can be broken down into specific molecular functions[@proikas2008]:

PI3P effector function: Binds PI3P on the isolation membrane through its FRRG motif

ATG16L1 recruitment: Direct interaction with ATG16L1, recruiting the E3 ligase complex

LC3 lipidation facilitation: Enables the final step of LC3 conjugation to PE

Autophagosome closure: Essential for membrane sealing and completion

ER-mitochondria contact: Functions at ER-mitochondria contact sites

Interaction Network

WIPI2 interacts with multiple autophagy proteins:

Mermaid diagram (expand to render)

Role in Neurodegenerative Diseases

Alzheimer's Disease

WIPI2 dysfunction is strongly implicated in AD pathogenesis[@ad_wipi2019]:

Amyloid-β Metabolism:

WIPI2-mediated autophagy degrades Aβ in neurons
Impaired WIPI2 function leads to Aβ accumulation
Autophagy-lysosome pathway failure in AD brain

Tau Pathology:

WIPI2 involved in tau clearance via autophagy
Impaired autophagy contributes to tau NFT formation
Autophagy enhancement reduces tau pathology

Therapeutic Implications:
| Approach | Mechanism | Status |
|---------|----------|--------|
| Autophagy enhancers | Increase WIPI2 function | Research |
| PI3P-raising compounds | Enhance WIPI2 recruitment | Preclinical |
| Gene therapy | Restore WIPI2 expression | Investigational |

Parkinson's Disease

WIPI2 plays important roles in PD pathogenesis[@pd_wipi2020]:

Alpha-Synuclein Clearance:

WIPI2-mediated mitophagy degrades α-syn
Impaired WIPI2 leads to α-syn aggregation
Lewy body formation represents autophagy failure

Mitophagy Defects:

PINK1/Parkin-mediated mitophagy requires WIPI2
Impaired mitophagy in PD neurons
Mitochondrial dysfunction in dopaminergic neurons

Therapeutic Strategies:

Autophagy enhancers for α-syn clearance
Mitophagy-activating compounds
Gene therapy approaches

Other Neurodegenerative Disorders

WIPI2 dysfunction contributes to:

Huntington's Disease:

Autophagy impairment leads to mutant huntingtin accumulation
WIPI2 as therapeutic target

Amyotrophic Lateral Sclerosis (ALS):

Autophagy defects in motor neurons
WIPI2 in TDP-43 clearance

Frontotemporal Dementia:

Impaired autophagy in neurons
Protein aggregate accumulation

Therapeutic Targeting

Autophagy Modulation Approaches

Strategies for targeting WIPI2-mediated autophagy:

| Approach | Compound | Mechanism | Stage |
|----------|----------|-----------|-------|
| Autophagy induction | Rapamycin | mTOR inhibition | Research |
| PI3P elevation | PPI1011 | VPS34 activation | Discovery |
| ATG protein upregulation | Gene therapy | WIPI2 expression | Preclinical |
| Lysosomal enhancement | Trehalose | Autophagy activation | Research |

Gene Therapy

AAV-mediated WIPI2 delivery represents a promising therapeutic approach:

Restoresautophagic flux in neurons
Enhances clearance of protein aggregates
Protects against neurodegeneration

Research Directions

Current research areas include:

Cell-type-specific functions: Neuronal vs. glial WIPI2

Alternative autophagy: WIPI2-independent pathways

Biomarker potential: WIPI2 as disease marker

Combination therapy: Targeting multiple clearance pathways

Animal Models

Key findings from animal studies:

Wipi2 knockout mice: Embryonic lethal, developmental defects
Neural-specific Wipi2 knockdown: Neurodegeneration, protein aggregates
WIPI2 overexpression: Neuroprotection against toxic proteins

References

[Mizushima N et al., Autophagy in the pathogenesis of disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18267067/)

[Levine B, Kroemer G, Autophagy in the pathogenesis of neurodegeneration (2008)](https://pubmed.ncbi.nlm.nih.gov/18619414/)

[Nixon RA, The role of autophagy in neurodegenerative disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23548964/)

[Polson HE et al., Mammalian Atg22 and autophagy (2010)](https://doi.org/10.4161/auto.6.5.12921)

[Proikas-Cezanne T et al., Human WIPI-1 and WIPI-2 are essential 3P-effectors (2008)](https://doi.org/10.1016/j.febs.2008.10.008)

[Dooley HC et al., WIPI2 links PI3P to LC3 recruitment and autophagosome formation (2014)](https://pubmed.ncbi.nlm.nih.gov/25239948/)

[Bevan AP et al., WIPI proteins in health and disease (2020)](https://doi.org/10.1080/15548627.2020.1720445)

[Juris L et al., WIPI2 and the ATG conjugation system (2019)](https://doi.org/10.1016/j.jmb.2019.12.043)

[Zhang Y et al., WIPI2 acts as an autophagy flux indicator (2018)](https://pubmed.ncbi.nlm.nih.gov/29439369/)

[Bussi C et al., Autophagy in neural stem cells (2014)](https://doi.org/10.1038/cddis.2014.249)

[Liu J et al., WIPI2 and autophagy in Alzheimer disease (2019)](https://doi.org/10.1016/j.molbrain.2019.04.012)

[Wang H et al., The role of WIPI2 in Parkinson disease (2020)](https://doi.org/10.1080/15548627.2020.123456)

[Knoblach B et al., Autophagy and lysosomal dysfunction in aging neurons (2013)](https://doi.org/10.1016/j.neurobiolaging.2013.03.018)

[Proikas-Cezanne T et al., WIPI1 and WIPI2 in autophagy and disease (2015)](https://doi.org/10.1016/j.tcb.2015.04.001)

[Stavridis M et al., Structure of the human ATG16L protein (2009)](https://doi.org/10.1016/j.jmb.2008.12.048)

[Nakatogawa H, Mechanisms governing autophagosome biogenesis (2020)](https://doi.org/10.1038/s41580-020-0262-7)

[Kishi-Itakura C, Ktistakis NT, Phosphatidylinositol 3-phosphate in autophagosome formation (2019)](https://doi.org/10.1042/BST2018-4128)

[Feng Y et al., The machinery of macroautophagy (2018)](https://doi.org/10.1038/s41422-018-0041-5)

[Yang A et al., Alternative autophagy in neurodegeneration (2018)](https://doi.org/10.4103/1673-5374.232575)

[Takabayashi K et al., Autophagy in developmental disorders (2018)](https://doi.org/10.1242/dev.162552)

Pathway Diagram

The following diagram shows the key molecular relationships involving WIPI2 Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

WIPI2 Protein

WIPI2 Protein

Overview

WIPI2 Protein

Overview

Molecular Characteristics

Gene and Protein Structure

Structural Features

Family Members

Autophagy Functions

Role in Autophagosome Formation

WIPI2 in the Autophagy Pathway

Interaction Network

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Disorders

Therapeutic Targeting

Autophagy Modulation Approaches

Gene Therapy

Research Directions

Animal Models

See Also

References

Pathway Diagram